PPD and Clinical Ink partner on process for lupus assessment
US contract research organisation PPD and clinical technology company Clinical Ink have jointly developed a systemic lupus erythematosus (SLE) assessment…
All articles by Johney
Johney
-
-
Merck reports data from Phase III KEYNOTE-598 trial
Merck has reported first-time data from the Phase 3 KEYNOTE-598 trial analysing KEYTRUDA, its anti-PD-1 therapy, along with ipilimumab (Yervoy)…
-
Abivax doses first patient in Phase II/III Covid-19 clinical trial
French biotechnology company Abivax has dosed the first patient in its Phase II/III study of ABX464 in Covid-19 patients at…
-
IQVIA and LMC Manna Research to launch Prime Site in Canada
IQVIA has entered a strategic alliance with LMC Manna Research to launch its first Prime Site for clinical investigation in…
-
AES launches patient-transfer programme for biopharma companies
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Follow the latest updates of the outbreak on our timeline. Accelerated…
-
Novavax and Nucleus partner to launch Covid-19 vaccine trials
US-based biotechnology company Novavax has partnered with Nucleus Network to initiate the clinical trials for its Covid-19 vaccine SARS-CoV-2 Recombinant…
-
Aurora trial reveals possible drug to treat Lupus kidney disease
Aurora, a Phase III global trial presented by the National Kidney Foundation (NKF), has revealed a possible drug for the…
-
BELLUS Health completes patient enrolment in trial of BLU-5937
Canadian biopharmaceutical firm BELLUS Health has completed patient enrolment for its dose-escalation, placebo-controlled Phase II RELIEF trial of BLU-5937 in…
-
Algernon retains Novotech for trial of Ifenprodil in Covid-19 patients
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Follow the latest updates of the outbreak on our timeline.…
-
NantKwest doses first patient in Merkel cell carcinoma therapy trial
NantKwest has dosed the first patient in a Phase II trial of natural killer cells for second and third-line Merkel…